paperKB
coga / coga-kb
Help
Sign in

Chunk #41 — OBSERVATIONS — Treatment: — Non-FDA-Approved Medications for Treating Alcohol Use Disorder (Table 2) — Recommended Approach to Treatment:

Source
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
Embedded
yes

Text

Patients diagnosed with an AUD should be advised to substantially reduce or stop their alcohol use. Although recent guidelines on moderate drinking recommend that men consume no more than 2 drinks/day and women 1 drink/day, with no binge drinking63 a meta-analysis of nearly 600,000 participants showed a minimum all-cause mortality risk at a consumption level of about 1 drink/day, irrespective of sex.64 Together with brief counseling, a first-line medication such as oral naltrexone is well tolerated. It can be initiated at a once-daily dosage of 25 mg and increased to 50 mg after 3 days and 100 mg after 7 days.46 Studies have not directly compared the effects of requiring abstinence prior to initiating a medication to treat AUD. Although there is evidence that a longer period of abstinence may be useful with long-acting naltrexone treatment,66 studies of naltrexone67 and topiramate25 that did not require abstinence prior to treatment have shown superiority of the active medication to placebo treatment.